Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 28, 2016 - Issue 1
246
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Pulmonary function and serum pneumoproteins in professional ski waxers

, , , , , , & show all
Pages 7-13 | Received 09 Sep 2015, Accepted 06 Nov 2015, Published online: 20 Jan 2016

References

  • American Thoracic Society. (1987). Standardization of spirometry. Am Rev Respir Dis 136:1285–95.
  • Barregard L, Sällsten G, Andersson L, et al. (2008). Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress. Occup Environ Med 65:319–24.
  • Bernard A, Hermans C, Van Houte G. (1997). Transient increase of serum Clara cell protein (CC16) after exposure to smoke. Occup Environ Med 54:63–5.
  • Bernard A, Marchandise FX, Depelchin S, et al. (1992). Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 5:1231–8.
  • Bernard AM, Gonzalez-Lorenzo JM, Siles E, et al. (1994). Early decrease of serum Clara cell protein in silica-exposed workers. Eur Respir J 7:1932–7.
  • Berthoin K, Broeckaert F, Robin M, et al. (2004). Serum pneumoproteins and biomarkers of exposure to urban air pollution: a cross-sectional comparison of policemen and foresters. Biomarkers 9:341–52.
  • Bracco D, Favre JB. (1998). Pulmonary injury after ski wax inhalation exposure. Ann Emerg Med 32:616–19.
  • Brown JS, Gordon T, Price O, Asgharian B. (2013). Thoracic and respirable particle definitions for human health risk assessment. Part Fibre Toxicol 10:12.
  • Burgess JL, Nanson CJ, Bolstad-Johnson DM, et al. (2001). Adverse respiratory effects following overhaul in firefighters. J Occup Environ Med 43:467–73.
  • Christiani DC, Wang XR, Pan LD, et al. (2001). Longitudinal changes in pulmonary function and respiratory symptoms in cotton textile workers. A 15-yr follow-up study. Am J Respir Crit Care Med 163:847–53.
  • Comité Européen de Normalisation. (CEN). (1993). Workplaceathmospheres: size fraction definitions for measurement of airborne particles in the workplace. Brussels, Belgium: European Standard EN481, CEN.
  • Cotes JE. (1979). Lung function, 4th ed. London: Blackwell Scientific Publications, 246.
  • Dahlqvist M, Alexandersson R, Andersson B, et al. (1992). Exposure to ski-wax smoke and health effects in ski waxers. Appl Occup Environ Health 7:689–93.
  • Ellingsen DG, Ulvestad B, Andersson L, Barregard L. (2010). Pneumoproteins and inflammatory biomarkers in asphalt pavers. Biomarkers 15:498–507.
  • Freberg BI, Espeland O. (2007). Luftkvalitetoghelseieliteskiskyttersmøreboder. Enpilotstudie. NorskIdrettsmedisin 3:18 (in Norwegian).
  • Freberg BI, Olsen R, Daae HL, et al. (2014). Occupational exposure assessment of airborne chemical contaminants among professional ski waxers. Ann Occup Hyg 58:601–11.
  • Freberg BI, Olsen R, Thorud S, et al. (2013). Chemical exposure among professional ski waxers-characterization of individual work operations. Ann Occup Hyg 57:286–95.
  • Gambaretto G, Conte L, Fornasieri G, et al. (2003). Synthesis and characterization of a new class of polyfluorinated alkanes: tetrakis(perfluoroalkyl) alkane. J Fluorine Chem 121:57–63.
  • Gaunsbaek MQ, Rasmussen KJ, Beers MF, et al. (2013). Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury. Lung 191:295–303.
  • Giæver P. (2008). Lunge-sykdommer, 2nd ed. Oslo, Norway: Universitetsforlaget (Chapter 3). ISBN: 978-82-15-01152-3 (in Norwegian).
  • Hansen LT. (1991). Lungeskade i forbindelse med smøring av ski. Tidsskr nor Lægeforening 3:111 (in Norwegian).
  • Hartl D, Griese M. (2006). Surfactant protein D in human lung diseases. Eur J Clin Invest 36:423–35.
  • Helleday R, Segerstedt B, Forsberg B, et al. (2006). Exploring the time dependence of serum Clara cell protein as a biomarker of pulmonary injury in humans. Chest 130:672–5.
  • Hermans C, Bernard A. (1999). Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 159:646–78.
  • Hermans C, Dong P, Robin M, et al. (2003). Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16. Biomarkers 8:461–71.
  • Hermans C, Knoops B, Wiedig M, et al. (1999). Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 13:1014–21.
  • Hoegh SV, Sorensen GL, Tornoe I, et al. (2010). Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology 215:314–20.
  • Hoffman MD, Clifford PS, Varkey B. (1997). Acute effects of ski waxing on pulmonary function. Med Sci Sports Exerc 29:1379–82.
  • Hughes JMB, Pride NB. (2012). Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components. Am J Respir Crit Care Med 186:132–9.
  • Hämeri K, Aalto P, Kulmala M, et al. (1996). Formation of respirable particles during ski waxing. J Aerosol Sci 27:339–44.
  • Knöpfli B, Gűntensperger U, Schibler A, Villiger B. (1992). Akute Verschlecterungder CO-Diffusionskapazitätnach Expositionmit Skiwachsdämpfen. SchweizRundschauMed 81:884–7 (in German).
  • Lesur O, Bernard AM, Begin OL. (1996). Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers. Chest 109:467–74.
  • Liesivuori J, Kiviranta H, Laitinen J, et al. (1994). Airborne aerosols in application of polyfluoro polymer-based ski waxes. Ann Occup Hyg 38:931–7.
  • Ludwig Sr FJ. (1995). Gas chromatography of petroleum-derived waxes and high-molecular-mass linear alcohols and acids. J Chromatogr 718:119–29.
  • Madsen C, Durand KL, Nafstad P, et al. (2008). Associations between environmental exposures and serum concentrations of Clara cell protein among elderly men in Oslo, Norway. Environ Res 108:354–60.
  • Martin LD, Rochelle LG, Fischer BM, et al. (1997). Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators. Eur Respir J 10:2139–46.
  • McGee KA, Baumann NA. (2009). Procalcitonin: clinical utility in diagnosing sepsis. Clin Lab News 35:1–8.
  • Medarov BI, Pavlov VA, Rossoff L. (2008). Diurnal variations in human pulmonary function. Int J Clin Exp Med 1:267–73.
  • Mutti A, Corradi M, Goldoni M, et al. (2006). Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 129:1288–97.
  • National Work Environment Authority (Arbeidstilsynet). (2013). ForskriftomtiltaksverdierforfysiskeogkjemiskefaktorerIarbeidsmiljøet. Available from: www.arbeidstilsynet.no. [Last accessed: 10 Sept 2014].
  • Rogowski I, Gauvrit J-Y, Leonard D, Lanteri P. (2005). Typology of the gliding waxes in cross-country skiing: comparison between classifications based on the chemical composition and those based on the physical and physicochemical properties. Cold Reg Sci Technol 43:140–9.
  • Shaw RJ, Djukanovic R, Tashkin DP, et al. (2002). The role of small airways in lung disease. Respir Med 96:67–80.
  • Shijubo N, Honda Y, Itoh Y, et al. (1998). BAL surfactant protein A and Clara cell 10-kDa protein levels in healthy subjects. Lung 176:257–65.
  • Sorensen GL, Husby S, Holmskov U. (2007). Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 212:381–416.
  • Spengler CM, Shea SA. (2000). Endogenous circadian rhythm of pulmonary function in healthy humans. Am J Respir Crit Care Med 162:1038–46.
  • Stockfelt L, Sällsten G, Olin AC, et al. (2012). Effects on airways of short-term exposure to two kinds of wood smoke in a chamber study of healthy humans. Inhal Toxicol 24:47–59.
  • Strøm E, Alexandersen O. (1990). Lungeskade i forbindelse med smøring av ski. Tidsskr nor Lægeforening 110:3614–16 (in Norwegian).
  • Takahashi H, Kuroki Y, Tanaka H, et al. (2000). Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 162:258–63.
  • Ulvestad B, Randem BG, Andersson L, et al. (2007). Clara cell protein as a biomarker for lung epithelial injury in asphalt workers. J Occup Environ Med 49:1073–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.